Brokerage firm HSBC said that Biocon has launched a ₹4,500 crore QIP to raise funds for repaying financial obligations, including optionally convertible debentures (OCDs) issued to Goldman Sachs AIF.
Brokerage firm HSBC said that Biocon has launched a ₹4,500 crore QIP to raise funds for repaying financial obligations, including optionally convertible debentures (OCDs) issued to Goldman Sachs AIF.